T2-high asthma
MONDO:0956975A chronic asthma that is characterized by the pathophysiology phenotype combination (endotype) of early-onset allergic asthma, late-onset eosinophilic asthma, and aspirin-exacerbated respiratory disease.
47 clinical trials for this condition and its sub-types, 46 tagged with T2-high asthma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Nasal spray could tame tough asthma Flare-Ups
Disease control Not yet recruitingThis Phase 2 trial tests AD17002, a nasal spray that aims to calm the immune system in people with moderate to severe eosinophilic asthma that is not well controlled by current treatments. About 126 adults will receive either the spray or a placebo for 3 months. Researchers will …
Phase 2 • Sponsor: Advagene Biopharma Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Easier injections for asthma? study tests two delivery methods
Knowledge-focused Not yet recruitingThis study tests whether a prefilled autoinjector delivers the drug SHR-1703 as effectively as a standard prefilled syringe in healthy adults. The goal is to see if the autoinjector provides a similar level of drug in the blood, which could make future injections easier for peopl…
Phase 1 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Breath test could uncover hidden asthma inflammation in routine doctor visits
Knowledge-focused Not yet recruitingThis study uses a quick, non-invasive breath test (FeNO) to measure airway inflammation in adults with asthma who are treated in primary care or community specialty clinics. The goal is to see how many patients have type 2 inflammation, which often goes undetected. Researchers ho…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC